The ALPCO Calprotectin assay is a widely used diagnostic tool designed to measure calprotectin levels in human stool as a biomarker of intestinal inflammation. Calprotectin, a protein released by activated neutrophils, serves as a reliable indicator of inflammatory activity within the gastrointestinal tract. Elevated levels are commonly associated with conditions such as inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, making it a valuable non-invasive alternative to more invasive diagnostic procedures.

This clinical trial focuses on evaluating the accuracy, sensitivity, and clinical utility of the ALPCO Calprotectin assay in detecting and monitoring gastrointestinal inflammation.